Evidence map›Paper›PMID 35749510›Full record

Trial reportPloS one2022

Understanding the role of incentives for achieving and sustaining viral suppression: A qualitative sub-study of a financial incentives trial in Uganda.

Carol S Camlin, Kara Marson, Alex Ndyabakira, Monica Getahun, Devy Emperador, Ambrose Byamukama, Dalsone Kwarisiima, Harsha Thirumurthy, Gabriel Chamie

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02890459 (Innovative Incentive Strategies for Sustainable HIV Testing and Antiretroviral Treatment), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02890459 nacompletednot on this map

Innovative Incentive Strategies for Sustainable HIV Testing and Antiretroviral Treatment

TypeinterventionalSponsorUniversity of California, San FranciscoRan2016 to 2020Enrolled3,580ConditionsHIV/AIDSArmsPrize incentive - Low, Prize incentive - High, Escalating payment incentive, Travel Voucher, Standard care
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Carol S CamlinDepartment of Obstetrics, Gynecology & Reproductive Sciences, University of California San Francisco, San Francisco, California, United States of America.ORCID 0000-0001-5615-1164
Kara MarsonDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Alex NdyabakiraInfectious Diseases Research Collaboration, Kampala, Uganda.
Monica GetahunDepartment of Obstetrics, Gynecology & Reproductive Sciences, University of California San Francisco, San Francisco, California, United States of America.
Devy EmperadorDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Ambrose ByamukamaInfectious Diseases Research Collaboration, Kampala, Uganda.
Dalsone KwarisiimaInfectious Diseases Research Collaboration, Kampala, Uganda.
Harsha ThirumurthyPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Gabriel ChamieDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.

Funding

Innovative incentive strategies for sustainable HIV testing and linkage to careR01MH105254 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHAMIE, GABRIEL, THIRUMURTHY, HARSHA · 2015 to 2019
$3.0M
NIMH NIH HHS R01 MH105254
6 · The paper itself

Abstract

backgroundViral suppression among people living with HIV (PLHIV) is essential for protecting health and preventing HIV transmission, yet globally, rates of viral suppression are sub-optimal. Interventions to improve HIV prevention and care cascade outcomes remain vital. Financial incentives hold promise for improving these outcomes, yet to date, clinical trial results have been mixed.

methodsThis qualitative sub-study, embedded in a trial (NCT02890459) in Uganda to test whether incentives are effective for achieving viral suppression in PLHIV, sought to enhance our understanding of the factors that influence this outcome. Forty-nine (n = 49) PLHIV, purposely sampled to balance across gender, study arm, and viral suppression status, were interviewed to explore barriers and motivations for care engagement, adherence, and viral suppression, and attributions for decision-making, including perceived influence of incentives on behaviors.

resultsWhile many participants with undetectable viral load (VL) who received incentives said the incentives motivated their ART adherence, others expressed intrinsic motivation for adherence. All felt that incentives reduced burdens of transport costs, lost income due to time spent away from work, and food insecurity. Incentives may have activated attention and memory for some, as excitement about anticipating incentives helped them adhere to medication schedules. In comparison, participants who were randomized to receive incentives but had detectable VL faced a wider range, complexity and severity of challenges to care engagement. Notably, their narratives included more accounts of poor treatment in clinics, food insecurity, and severe forms of stigma. With or without incentives, adherence was reinforced through experiencing restored health due to ART, social support (especially from partners), and good quality counseling and clinical care.

conclusionsIn considering why incentives sometimes fail to achieve behavior change, it may be helpful to attend to the full set of factors- psychological, interpersonal, social and structural- that militate against the behavior change required to achieve behavioral outcomes. To be effective, incentives may need to be combined with other interventions to address the spectrum of barriers to care engagement.

Indexed as

HIV InfectionsMotivationHumansMedication AdherenceQualitative ResearchUgandaViral Load

Identifiers

PMID35749510
PMCPMC9231797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.